The largest database of trusted experimental protocols

21 protocols using rnaifect

1

Silencing CIB1 and ASK1 in Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
The target sequence [sense 5′-AAAGACAGCCTTAGCTTTGAG-3′] for human CIB1 RNAi was selected with the use of the siRNA target finder program of Ambion. The annealed oligonucleotides including sense and anti-sense strands of the target sequence were inserted into the pSUPER.retro vector (OligoEngine). As a control, annealed oligonucleotides containing a target sequence (sense 5′-GGCTACGTCCAGGAGCGCACC-3′) for a GFP shRNA were inserted into the same vector. The nucleotide sequences of the various inserts were confirmed by DNA sequencing. SH-SY5Y cells were transfected with pSUPER.retro vectors encoding either the control (GFP) or CIB1 shRNA, and stable transfectants were selected in the presence of puromycin (0.25 μg/ml). Rat CIB1 siRNA (sense 5′-AAGAGTCACTGCATACCCGAG-3′), Mouse ASK1 siRNA (sense 5′-AATTGCAGTCTGCACAGCCTTTCGG-3′), or control GFP siRNA (sense 5′-GGCTACGTCCAGGAGCGCACC-3′) oligonucleotides were obtained from Invitrogen and introduced into primary rat mesencephalic dopaminergic neurons by transfection for 48 h with the use of RNAiFect (Qiagen).
+ Open protocol
+ Expand
2

Lovastatin Lactone Cytotoxicity Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 24-well plates at a density of 1 × 105 cells per well (DNA fragmentation assays; Figure 8C, 8D), in 6-well plates at a density of 2 × 105 cells per well (Western blot analyses, Figure 8A, 8B, lower panel) and in 96-well plates at a density of 5 × 103 cells per well (WST-1 tests; Figure 8A, 8B, upper panel), and were allowed to adhere for 2-3 h. Transfection was performed as described previously [26 (link), 28 (link), 29 (link)]. In brief, cells were transfected with an equal ratio (w/v) of RNA to transfection reagent for 24 h in 10% DMEM prior to incubation with lovastatin lactone. Subsequently, cells were washed with PBS, transfected again in serum-free DMEM to provide constant transfection conditions, and incubation with vehicle or lovastatin lactone was started. Transfections were carried out using RNAiFect® as transfection reagent (Qiagen, Hilden, Germany). SiRNA was obtained from Qiagen. The nonsilencing negative control RNA was from Eurogentec (Cologne, Germany). Final concentrations of COX-2 SiRNA and non-silencing SiRNA were 2.5 μg/ml, respectively.
+ Open protocol
+ Expand
3

Culturing and Transfecting Dopaminergic Neuroblastoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human dopaminergic neuroblastoma SH-SY5Y cells were routinely maintained under a humidified atmosphere of 5% CO2 at 37 °C in DMEM (Invitrogen) supplemented with 10% FBS, penicillin (100 U/ml), and streptomycin (100 μg/ml). Transfection of cells was performed with Lipofectamine2000 (Invitrogen) for SH-SY5Y cells or RNAiFect (Qiagen) for primary mesencephalic neuronal cells.
+ Open protocol
+ Expand
4

Transient GP96 Expression Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfections were performed using Lipofectamine 2000 (Invitrogen) and RNAiFect (Qiagen) following manufacturer's instructions. GP96 ON-TARGETplus smartpools siRNA were purchased from Dharmacon (Thermo Fisher Scientific, Europe). Mammalian expression vectors used for transient GP96 expression were described previously [15] (link).
+ Open protocol
+ Expand
5

Cell Viability Assay with MTS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation and viability was assessed using the CellTiter 96® AQueous One solution cell proliferation assay (MTS; Promega GmbH, Mannheim, Germany). This assay contains a tetrazolium compound (MTS) and an electron coupling reagent, phenazine ethosulfate (PES). MTS can be bioreduced by cells into formazan, which is soluble in cell culture medium. The quantity of the formazan product as measured spectrophotometrically is directly proportional to the number of viable cells. The assay measures dehydrogenase enzyme activity found in metabolically active cells. MCF-7 or MDA-MB-231 cells were seeded in 96-well plates at a density of 1–3×104 cells per well in 100 µl RPMI 1640 medium, and incubated overnight at 37°C. The cells were washed 2 times with PBS then different concentration (10, 25, 50,75, 100, 250, 500, 1000 nM) of siRNAs were mixed with 1.5 µl RNAifect (Qiagen GmbH) and added at a final volume of 100 µl per well. After 48 h, the Aqueous One Solution containing MTS/PES was added and the optical density was measured at 490 nm using an ELx808 microplate reader (BioTek Instruments GmbH, Bad Friedrichshall, Germany) after 6 h. This experiment was performed in triplicate wells. The absorbance measured from control siRNA (siNON) treatment was normalized to 100% viability.
+ Open protocol
+ Expand
6

Overexpression and Silencing of IRF7 in HCEn Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCEn cells were transfected with an IRF7-expressing plasmids using a CMV promoter (pCMV6 backbone, OriGene, Rockville, MD) with gene porter 3000 (Genlantis, San Diego, CA). The extracted proteins were confirmed by western blot analyses using an anti-IRF7 antibody (Santa Cruz Biotechnology, Dallas, TX) and HRP-conjugated secondary antibody (Cell Signaling, Danvers, MA).
For siRNA transfection, HCEn cells were transfected with IRF7 siRNA (Santa Cruz Biotechnology, Dallas, TX) using RNAifect (Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
7

Transfection of E13 Epithelia

Check if the same lab product or an alternative is used in the 5 most similar protocols
E13 epithelia were transfected with antagomirs (Exiqon) or mimics (Ambion) using RNAiFect (Qiagen) reagents as previously described (Rebustini, et al., 2012 (link)).
+ Open protocol
+ Expand
8

siRNA Knockdown of Cytoskeletal Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following duplexed siRNAs (predesigned Ambion Silencer Select) were obtained from Life Technologies: LIMK 1, 156129 and s69232; LIMK 2, 156133 and s69236; TPPP/p25, s91408 and s91407; nonmuscle cofilin, Cfl1, s63902; cdc42 siRNA, s63741; and negative control siRNA # 1. SMGs were transfected with 500 nM siRNA using RNAiFect (Qiagen, Valencia, CA) and cultured for 24–48 h, as we reported previously (Daley et al., 2009 (link))
+ Open protocol
+ Expand
9

FAP-α Depletion via RNA Interference

Check if the same lab product or an alternative is used in the 5 most similar protocols
Depletion of FAP-α was performed with two siRNA sequences (SI00064050; SI00064057, 1 μg of each) and 6 μl RNAiFect (all from Qiagen, Germantown, MD, USA). Optimal transfection conditions were determined by Alexa Fluor 555 labelled non-silencing siRNA, with a scrambled sequence, which was also used as negative control. siRNA targeting Lamin A/C (SI03650332) served as positive control.
+ Open protocol
+ Expand
10

Lamin A Variant Expression Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression vector pcDNA™5/FRT/TO (Invitrogen) was cut with Bam H I and Xho I. Fragments of lamin A, progerin, lamin A R133L, or lamin A L140R were ligated into the corresponding restriction sites of pcDNA™5/FRT/TO. The resulting expression vectors were transfected into HEK293 cells by using Fugene. We created vectors based on pLNCX2 (Clontech, Palo Alto, CA, USA) that expressed wild-type lamin A or progerin for retroviral infection, which was done as described previously [26 (link)]. Briefly, VSMCs or HUVECs (passages 4-6) were plated at 5×105 cells in 100-mm dishes at 24 hours before infection. Then the culture medium was replaced by retroviral stock medium supplemented with 8 μg ml−1 polybrene (Sigma). From 48 hours after infection, the cells were selected by culture for 7 days in 500 μg ml−1 G418. After selection, 2×105 cells were seeded in 100-mm dishes on the 8th day post-infection, which was designated as day 0. The respective empty vectors were used as controls. In some experiments, after retroviral infection had been performed, siRNAs purchased from Ambion or Invitrogen were transfected at 10 nmol l−1 with RNAiFect (Qiagen) or Lipofectamine RNAiMAX (Invitrogen) according to the instructions of the respective manufacturers.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!